CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 4,561 enrolled
Drug / intervention
Oseltamivirdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00884117
NCT00884117N/ACompleted

Influenza Resistance Information Study (IRIS)

Hoffmann-La Roche·observational·Posted Apr 20, 2009·Updated Oct 19, 2016

In Brief

An observational study evaluating Oseltamivir for Influenza. Completed, enrolled 4,561 participants across 8 sites in 8 countries.

Detailed Summary

This study will assist in the early detection of influenza resistant to antivirals and will monitor the clinical outcome of adults and children infected with influenza according to subtype and susceptibility. Participants clinically diagnosed with influenza will undergo a rapid diagnostic test and viral sampling at Baseline and on Days 3, 6, and 10. Participants will be clinically managed according to local guidelines and the decision to treat/not treat will be at the discretion of the Investigator.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsInfluenza
CountriesAustralia, France, Germany, Hong Kong, Netherlands, Norway, Poland, United States
Collaborators--

Timeline

N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedApr 20, 2009
Enrollment StartJan 1, 2009
Primary CompletionNov 1, 2015
TodayJul 2, 2026
Enrollment to primary: 6.8 yearsPosted 17.2 years ago

Interventions

Oseltamivirdrug

Participants may receive treatment at the discretion of the investigator according to local practice standards, and there is no protocol-specified intervention. However, analyses will be presented separately for participants treated with oseltamivir during the course of the study.